Segantii Capital Management’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-16,666
| Closed | -$118K | – | 203 |
|
2023
Q2 | $118K | Hold |
16,666
| – | – | 0.01% | 173 |
|
2023
Q1 | $169K | Hold |
16,666
| – | – | 0.01% | 274 |
|
2022
Q4 | $167K | Hold |
16,666
| – | – | 0.01% | 373 |
|
2022
Q3 | $164K | Hold |
16,666
| – | – | ﹤0.01% | 493 |
|
2022
Q2 | $163 | Hold |
16,666
| – | – | ﹤0.01% | 495 |
|
2022
Q1 | $163K | Hold |
16,666
| – | – | ﹤0.01% | 521 |
|
2021
Q4 | $162K | Hold |
16,666
| – | – | 0.01% | 496 |
|
2021
Q3 | $162K | Buy |
+16,666
| New | +$162K | 0.01% | 439 |
|